Form Bio Co. Ltd. (377220) — Financial Flexibility Index
Form Bio Co. Ltd. (377220) has a Financial Flexibility Index of -0.03x as of June 2026. Free cash flow of ₩-1.38 Billion (operating CF ₩-1.40 Billion minus capex ₩18.38 Million) represents 0% of total liabilities (₩39.64 Billion). Check Form Bio Co. Ltd. investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Form Bio Co. Ltd. Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Form Bio Co. Ltd. across 7 annual periods. For the full cash flow conversion analysis, see Form Bio Co. Ltd. operating cash flow efficiency.
Annual Financial Flexibility Index for Form Bio Co. Ltd. (2019–2025)
Year-by-year free cash flow to debt coverage for Form Bio Co. Ltd.. Explore debt repayment capacity of Form Bio Co. Ltd. to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.23x | ₩-8.81 Billion | ₩-10.07 Billion | ₩39.11 Billion | ▲ +47.7% |
| 2024 | -0.43x | ₩-13.81 Billion | ₩-14.70 Billion | ₩32.07 Billion | ▼ -130.3% |
| 2023 | -0.19x | ₩-4.15 Billion | ₩-20.85 Billion | ₩22.19 Billion | ▼ -108.3% |
| 2022 | 2.24x | ₩13.16 Billion | ₩-2.02 Billion | ₩5.87 Billion | ▲ +168.9% |
| 2021 | 0.83x | ₩10.00 Billion | ₩-1.17 Billion | ₩11.99 Billion | ▼ -19.9% |
| 2020 | 1.04x | ₩22.24 Billion | ₩15.61 Billion | ₩21.35 Billion | ▲ +350.6% |
| 2019 | 0.23x | ₩7.96 Billion | ₩5.68 Billion | ₩34.45 Billion | — |